Infectious diseases [680]

Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity

European journal of medicinal chemistry

Alvey L, Prado S, Saint-Joanis B, Michel S, Koch M, Cole ST, Tillequin F, Janin YL

A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial

Bioorganic & medicinal chemistry

Alvey L, Prado S, Huteau V, Saint-Joanis B, Michel S, Koch M, Cole ST, Tillequin F, Janin YL

Antituberculosis drugs: ten years of research

Bioorganic & medicinal chemistry

Janin YL

Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Kordulakova, J.; Janin, Y. L.; Liav, A.; Barilone, N.; Vultos, T. D.; Rauzier, J.; Brennan, P. J.; Gicquel, B.; Jackson, M.

Antimycobacterial benzofuro[3,2-f]chromenes from a 5-bromochromen-6-ol

Synthesis

Prado, S.; Toum, V.; Saint-Joanis, B.; Michel, S.; Koch, M.; Cole, S. T.; Tillequin, F.; Janin, Y. L.

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues

Bioorganic & medicinal chemistry

Prado S, Janin YL, Saint-Joanis B, Brodin P, Michel S, Koch M, Cole ST, Tillequin F, Bost PE

Molecular typing of Cryptococcus neoformans serotype D clinical isolates

Journal of clinical microbiology

Dromer F, Varma A, Ronin O, Mathoulin S, Dupont B